ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1028

Semi-Quantitative Assessment of Bone Marrow Edema and Synovitis-Effusion in Osteoarthritis with the Knee Inflammation MRI Scoring System:  A Target Lesion Based Methodology

Walter P. Maksymowych1, Ulrich Weber2, Marcus Pianta3 and Robert GW Lambert3, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, Balgrist University Hospital, Zurich, Switzerland, 3Radiology, University of Alberta, Edmonton, AB, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Bone marrow, Inflammation, magnetic resonance imaging (MRI) and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose: Current MRI scoring methods for assessment of bone marrow lesions (BML) in the knee of patients with osteoarthritis rely on a complex subdivision of the knee into 15 subregions and then a further estimation of the proportion of subregion with BML1. Scoring of synovitis-effusion (S-E) is based on a restricted grading scheme assessing the whole joint (0= none, 3 = large) which limits responsiveness. We aimed to develop and conduct preliminary validation of an MRI method for direct semi-quantitative assessment of BML and S-E, that focuses on detection of change (Knee Inflammation MRI Scoring System (KIMRISS)).

Methods: Assessment of BML is based on assessment of coronal and sagittal images for medial/lateral knee compartments and axial/sagittal images for patella-femoral compartment using a fluid-sensitive MRI sequence (STIR, T2 FatSat). Size of a BML lesion is defined according to the largest continuous increase in signal assessed in all dimensions and number of slices in which the increased signal can be detected (small = <1cm in all dimensions on ≤ 2 slices; moderate = >1cm but NOT >2 cm in ≥2 dimensions; large = >2cm in ≥ 2 dimensions). A weighting is applied to change in BML size (1.5x and 2x for moderate and large lesions, respectively). Size of S-E is assessed in each of 4 compartments (medial and lateral patellar recess, suprapatellar, semimembranosus bursa) according to a 0-4 grading scheme and a weighting is applied for change in S-E size (1.5x and 2x for grade 3 and 4 lesions, respectively). MRI scans were performed on the knee joints of 15 patients enrolled into an open label trial of an anti-TNF agent in subjects with persistent pain due to knee osteoarthritis and clinical evidence of effusion who had failed conventional therapy. Scans were performed at baseline and 12 weeks and independently reviewed by 3 readers blinded to timepoint. Reliability of change scores was assessed by intraclass correlation coefficient (ICC) and responsiveness by standardized response mean (SRM). We assessed correlations with WOMAC pain, patient global, and target joint clinical effusion score.

Results: Reliability of detection of change in KIMRISS BML (ICC for 3 reader pairs = 0.71. 0.73. 0.75), KIMRISS S-E (ICC for 3 reader pairs = 0.78, 0.82, 0.86), and Total KIMRISS (ICC for 3 reader pairs = 0.77, 0.81, 0.89) was very good with substantial responsiveness after 12 weeks of treatment (Table). Improvement in Total KIMRISS score was observed in 12 patients although change in either the Total KIMRISS or KIMRISS BML did not significantly correlate with change in WOMAC pain or patient global. KIMRISS S-E did not correlate with target joint effusion score.

 

ICC (3 readers)

SRM

KIMRISS BML

0.73

0.82

KIMRISS Synovitis-Effusion

0.82

0.70

KIMRISS Total

0.81

0.88

Conclusion: The KIMRISS methodology for MRI-based semi-quantitative assessment of acute lesions in knee joints is responsive and is capable of reliably detecting change. It merits further validation in inflammatory knee joint disorders.

  1.  Hunter et al. Ostearthritis Cartilage 2011; 19: 990 

Disclosure:

W. P. Maksymowych,
None;

U. Weber,
None;

M. Pianta,
None;

R. G. Lambert,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/semi-quantitative-assessment-of-bone-marrow-edema-and-synovitis-effusion-in-osteoarthritis-with-the-knee-inflammation-mri-scoring-system-a-target-lesion-based-methodology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology